Latest 8-K filings

Bowhead Specialty Holdings Inc. has entered into a definitive agreement to be acquired by American Family Mutual Insurance Company, S.I. for $34.00 per share in cash, valuing the company at approximately $1.2 billion.

W.W. Grainger, Inc. announced the resignation of its Senior Vice President and Chief Financial Officer, Deidra C. Merriwether, effective September 4, 2026, and the appointment of Laurie R. Thomson as interim CFO.

AGCO Corporation announces executive leadership transitions, appointing Indira Agarwal as CFO and Damon Audia to lead PTx & Corporate Strategy.

News Corporation has provided an update on its ongoing stock repurchase program, detailing recent buyback activity for its Class A and Class B common stock.

Edible Garden AG Incorporated announced an expanded multi-year private label supply agreement with a major Midwest big-box retailer, extending their partnership through December 31, 2028.

Hess Midstream LP announced its estimated results for the second quarter of 2026, reporting net income of $173.7 million and reaffirming full-year guidance.

Strategy Inc. reported on August 3, 2026, updates regarding its at-the-market offering, bitcoin sales and holdings, and share repurchase programs, alongside dividend declarations.

Strive, Inc. announced the purchase of 20 bitcoin and provided an update on its cash, digital asset, and stock holdings as of July 31, 2026.

Brookfield Asset Management has finalized its acquisition of Oaktree, consolidating its credit platform and expanding its global reach.

Lindblad Expeditions Holdings announced robust second-quarter 2026 financial results, showcasing a 19% revenue increase to $199.2 million and a significant improvement in net loss.

Rocket Pharmaceuticals announced a positive clinical safety update for its RP-A501 gene therapy in Danon disease, with initial patients showing good tolerance and no major adverse events.

Tyson Foods announced third quarter 2026 results, showcasing strength in its Chicken and Prepared Foods segments, with sales flat year-over-year and adjusted operating income up 8%.

Twist Bioscience announced record revenue of $118.4 million for its fiscal third quarter of 2026, a 23% increase year-over-year, and raised its full-year revenue guidance.

Cocrystal Pharma announced a $5 million private placement with existing investor OPKO Health, Inc., to advance its antiviral drug candidate programs.

Sally Beauty Holdings announced third quarter fiscal 2026 results, showing a slight increase in net sales and flat comparable sales, alongside significant growth in GAAP and Adjusted Diluted EPS.

BCB Bancorp Inc. announced a second-quarter net loss of $14.8 million, a significant downturn from the previous quarter and year-ago period, while also proposing a move of its state of incorporation to Delaware.

Ocular Therapeutix announced a clear FDA-aligned path for its AXPAXLI NDA submission in Q4 2026, supported by positive Phase 3 data and a strong cash position extending into 2028.

SmartKem, Inc. announced a definitive agreement to combine with Ferrox Critical Minerals, Ltd. in an all-stock transaction valued at approximately $125 million, aiming for vertical integration.

TG Therapeutics reported robust second quarter 2026 results, driven by significant BRIUMVI revenue growth, leading to an upward revision of full-year financial targets.

Tonix Pharmaceuticals announced positive minutes from a Type C FDA meeting, confirming alignment on the design for a Phase 2 field study of its TNX-4800 to prevent Lyme disease.

Krystal Biotech announced robust second quarter 2026 financial and operating results, highlighted by significant global revenue growth for VYJUVEK and promising updates across its diverse clinical pipeline.

Seaport Therapeutics announced its second quarter 2026 financial results, detailing progress in its clinical trials for major depressive disorder and generalized anxiety disorder, alongside a robust cash position post-IPO.

Genprex, Inc. announces a collaboration with Roche Diagnostics to validate TROP2 and PTEN biomarkers for patient selection in non-small cell lung cancer clinical trials.

D-Wave Quantum Inc. and Nasdaq Verafin have announced a collaboration to explore the use of quantum computing for enhanced financial crime detection.

Two Harbors Investment Corp. announces progress on its merger with CrossCountry Intermediate Holdco, LLC, clarifying dividend details and anticipating closing upon final regulatory approval.

Autolus Therapeutics plc has entered into a $250 million senior secured notes facility with Perceptive Credit Holdings V, LP, alongside the issuance of warrants, to fund its operations and development.

BioXcel Therapeutics has entered into an Eleventh Amendment to its Credit Agreement, deferring a principal payment and reducing liquidity covenants.

Glaukos Corporation presented an investor presentation highlighting its innovative pipeline, strong financial health, and strategic focus on interventional glaucoma and keratoconus treatments.

Public Policy Holding Company, Inc. announces the acquisition of The Advocacy Partners, a Florida-based government relations firm, expected to be immediately earnings and margin accretive.

Marriott International announced robust second quarter 2026 financial results, driven by global RevPAR growth and a record development pipeline, leading to an upward revision of full-year RevPAR expectations.